AdvaMed said it named Shaye Mandle, CEO of Minnesota’s LifeScience Alley trade association, as chairman of its State Medical Technology Alliance.
“The medical technology industry is a hallmark of U.S. innovation represented by a community of people dedicated to improving and saving lives. Now more than ever, medical technology has the opportunity to help deliver better and more affordable care to patients worldwide. The efforts of SMTA members are critical to providing our elected leaders with the information needed to ensure the full national and global impact of this vital industry,” Mandle said in prepared remarks. “It is an honor to have this opportunity to work together with our SMTA members, the team at AdvaMed, and our elected leaders to support our medical technology innovators in delivering life-changing innovations. Medical technology improves countless lives every day and I am proud to represent the people making it happen.”
“I look forward to Shaye’s leadership as we advance policies to help ensure timely patient access to medical innovations and highlight the important role our industry plays as an engine of medical and economic progress,” added J.C. Scott, AdvaMed’s senior executive vice president for government affairs. “The SMTA has consistently supported the medical technology industry on the federal, state and local levels, an industry that helps patients live longer, healthier lives while lowering long-term health care costs.”
Shape Memory Therapeutics taps ex-Vascular Dynamics CFO Rupel for CEO
Shape Memory Therapeutics tapped former Vascular Dynamics CFO Ted Ruppel to be its new president and chief executive, replacing James Lancaster, who will stay on as CFO.
Prism Medical CEO McIntyre takes leave to fight cancer
Prism Medical (TSX:PM) said chairman & CEO Andrew McIntyre is taking a 6-month leave of absence for chemotherapy following a diagnosis of non-Hodgkin lymphoma. Vice chairman John Charles was named interim CEO in McIntyre’s absence.
Ventripoint shutters Seattle office after key execs’ abrupt departures
Ventripoint Diagnostics (TSX:VPT) said it shuttered its Seattle office after the abrupt departures of 3 key employees. Clinical affairs & development vice president James Bodtke operations director Jeff Jellum regional account manager Huy Le all left the company in the space of 3 days, the company said. Ventripoint named Tom Elias as interim operations manager.
- Direct Flow Medical names UVA’s Lim as co-principal investigator
- NeoChord snags Experian’s Adels for clinical affairs veep slot
- Edwards Lifesciences names former Stanford Hospital CEO Marsh to board
- RTI Surgical adds Water Street Healthcare’s Sweeney, ex-Covidien exec McEachin to board
- InnFocus elevates medtech vet Lindholm to executive chairman